HEADER HYDROLASE 30-AUG-05 2AVV TITLE KINETICS, STABILITY, AND STRUCTURAL CHANGES IN HIGH RESOLUTION CRYSTAL TITLE 2 STRUCTURES OF HIV-1 PROTEASE WITH DRUG RESISTANT MUTATIONS L24I, TITLE 3 I50V, AND G73S COMPND MOL_ID: 1; COMPND 2 MOLECULE: POL POLYPROTEIN; COMPND 3 CHAIN: A, B, D, E; COMPND 4 FRAGMENT: RETROPEPSIN; COMPND 5 SYNONYM: HIV-1 PROTEASE; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: COMPLEXED WITH INDINAVIR SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: GAG-POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS DRUG RESISTANCE, HIV-1 PROTEASE, INDINAVIR, SUBSTRATE ANALOG, NON- KEYWDS 2 ACTIVE SITE MUTANTS., HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR F.LIU,P.I.BOROSS,Y.F.WANG,J.TOZSER,J.M.LOUIS,R.W.HARRISON,I.T.WEBER REVDAT 4 23-AUG-23 2AVV 1 REMARK REVDAT 3 20-OCT-21 2AVV 1 REMARK SEQADV REVDAT 2 24-FEB-09 2AVV 1 VERSN REVDAT 1 24-JAN-06 2AVV 0 JRNL AUTH F.LIU,P.I.BOROSS,Y.F.WANG,J.TOZSER,J.M.LOUIS,R.W.HARRISON, JRNL AUTH 2 I.T.WEBER JRNL TITL KINETIC, STABILITY, AND STRUCTURAL CHANGES IN JRNL TITL 2 HIGH-RESOLUTION CRYSTAL STRUCTURES OF HIV-1 PROTEASE WITH JRNL TITL 3 DRUG-RESISTANT MUTATIONS L24I, I50V, AND G73S. JRNL REF J.MOL.BIOL. V. 354 789 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16277992 JRNL DOI 10.1016/J.JMB.2005.09.095 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.148 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.141 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2798 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 56005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.138 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.130 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2414 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 48186 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3032 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 104 REMARK 3 SOLVENT ATOMS : 380 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3395.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 3282.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 46 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 34236 REMARK 3 NUMBER OF RESTRAINTS : 44692 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 ANGLE DISTANCES (A) : 0.027 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.025 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.048 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.056 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.028 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.035 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.077 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY ? REMARK 4 REMARK 4 2AVV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1000034374. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 95.0 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56309 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.23900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1DAZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CITRATE/PHOSPHATE BUFFER, PH 6.0, REMARK 280 SATURATED AMMONIUM SULPHATE, 40%, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.36000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 8 CD - NE - CZ ANGL. DEV. = 9.1 DEGREES REMARK 500 ARG B 41 CD - NE - CZ ANGL. DEV. = 13.2 DEGREES REMARK 500 ARG B 41 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG B 41 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG B 57 CD - NE - CZ ANGL. DEV. = 9.1 DEGREES REMARK 500 ARG B 87 NE - CZ - NH1 ANGL. DEV. = 5.6 DEGREES REMARK 500 GLY D 51 C - N - CA ANGL. DEV. = -13.8 DEGREES REMARK 500 ARG D 57 CD - NE - CZ ANGL. DEV. = 10.1 DEGREES REMARK 500 ARG D 87 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 GLY E 51 C - N - CA ANGL. DEV. = -15.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MK1 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MK1 E 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY E 603 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AVM RELATED DB: PDB REMARK 900 RELATED ID: 2AVO RELATED DB: PDB REMARK 900 RELATED ID: 2AVQ RELATED DB: PDB REMARK 900 RELATED ID: 2AVS RELATED DB: PDB DBREF 2AVV A 1 99 UNP P04587 POL_HV1B5 69 167 DBREF 2AVV B 1 99 UNP P04587 POL_HV1B5 69 167 DBREF 2AVV D 1 99 UNP P04587 POL_HV1B5 69 167 DBREF 2AVV E 1 99 UNP P04587 POL_HV1B5 69 167 SEQADV 2AVV LYS A 7 UNP P04587 GLN 75 ENGINEERED MUTATION SEQADV 2AVV ILE A 33 UNP P04587 LEU 101 ENGINEERED MUTATION SEQADV 2AVV ILE A 63 UNP P04587 LEU 131 ENGINEERED MUTATION SEQADV 2AVV ALA A 67 UNP P04587 CYS 135 ENGINEERED MUTATION SEQADV 2AVV SER A 73 UNP P04587 GLY 141 ENGINEERED MUTATION SEQADV 2AVV ALA A 95 UNP P04587 CYS 163 ENGINEERED MUTATION SEQADV 2AVV LYS B 7 UNP P04587 GLN 75 ENGINEERED MUTATION SEQADV 2AVV ILE B 33 UNP P04587 LEU 101 ENGINEERED MUTATION SEQADV 2AVV ILE B 63 UNP P04587 LEU 131 ENGINEERED MUTATION SEQADV 2AVV ALA B 67 UNP P04587 CYS 135 ENGINEERED MUTATION SEQADV 2AVV SER B 73 UNP P04587 GLY 141 ENGINEERED MUTATION SEQADV 2AVV ALA B 95 UNP P04587 CYS 163 ENGINEERED MUTATION SEQADV 2AVV LYS D 7 UNP P04587 GLN 75 ENGINEERED MUTATION SEQADV 2AVV ILE D 33 UNP P04587 LEU 101 ENGINEERED MUTATION SEQADV 2AVV ILE D 63 UNP P04587 LEU 131 ENGINEERED MUTATION SEQADV 2AVV ALA D 67 UNP P04587 CYS 135 ENGINEERED MUTATION SEQADV 2AVV SER D 73 UNP P04587 GLY 141 ENGINEERED MUTATION SEQADV 2AVV ALA D 95 UNP P04587 CYS 163 ENGINEERED MUTATION SEQADV 2AVV LYS E 7 UNP P04587 GLN 75 ENGINEERED MUTATION SEQADV 2AVV ILE E 33 UNP P04587 LEU 101 ENGINEERED MUTATION SEQADV 2AVV ILE E 63 UNP P04587 LEU 131 ENGINEERED MUTATION SEQADV 2AVV ALA E 67 UNP P04587 CYS 135 ENGINEERED MUTATION SEQADV 2AVV SER E 73 UNP P04587 GLY 141 ENGINEERED MUTATION SEQADV 2AVV ALA E 95 UNP P04587 CYS 163 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE SER THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE SER THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 D 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 D 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 D 99 ILE ALA GLY HIS LYS ALA ILE SER THR VAL LEU VAL GLY SEQRES 7 D 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 D 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 E 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 E 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 E 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 E 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 E 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 E 99 ILE ALA GLY HIS LYS ALA ILE SER THR VAL LEU VAL GLY SEQRES 7 E 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 E 99 GLN ILE GLY ALA THR LEU ASN PHE HET MK1 A 901 90 HET ACY A 601 4 HET CL B 502 1 HET ACY B 602 4 HET CL D 501 1 HET MK1 E 902 90 HET ACY E 603 4 HETNAM MK1 N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY HETNAM 2 MK1 BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]- HETNAM 3 MK1 4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE HETNAM ACY ACETIC ACID HETNAM CL CHLORIDE ION HETSYN MK1 INDINAVIR FORMUL 5 MK1 2(C36 H47 N5 O4) FORMUL 6 ACY 3(C2 H4 O2) FORMUL 7 CL 2(CL 1-) FORMUL 12 HOH *380(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLY B 86 THR B 91 1 6 HELIX 3 3 GLY D 86 ILE D 93 1 8 HELIX 4 4 GLY E 86 ILE E 93 1 8 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N ASN A 98 O THR B 96 SHEET 4 A 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 LYS A 43 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O VAL A 56 N LYS A 45 SHEET 3 B 8 HIS A 69 GLY A 78 -1 O VAL A 77 N ARG A 57 SHEET 4 B 8 VAL A 32 GLU A 34 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 LYS B 43 GLY B 49 0 SHEET 2 C 8 GLY B 52 ILE B 66 -1 O GLY B 52 N GLY B 49 SHEET 3 C 8 HIS B 69 GLY B 78 -1 O ALA B 71 N ILE B 64 SHEET 4 C 8 VAL B 32 GLU B 34 1 N ILE B 33 O LEU B 76 SHEET 5 C 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 C 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 D 4 GLN D 2 ILE D 3 0 SHEET 2 D 4 THR E 96 ASN E 98 -1 O LEU E 97 N ILE D 3 SHEET 3 D 4 THR D 96 ASN D 98 -1 N ASN D 98 O THR E 96 SHEET 4 D 4 GLN E 2 ILE E 3 -1 O ILE E 3 N LEU D 97 SHEET 1 E 8 TRP D 42 GLY D 48 0 SHEET 2 E 8 PHE D 53 ILE D 66 -1 O GLN D 58 N LYS D 43 SHEET 3 E 8 HIS D 69 GLY D 78 -1 O VAL D 75 N TYR D 59 SHEET 4 E 8 VAL D 32 GLU D 34 1 N ILE D 33 O LEU D 76 SHEET 5 E 8 ILE D 84 ILE D 85 -1 O ILE D 84 N VAL D 32 SHEET 6 E 8 GLN D 18 LEU D 24 1 N LEU D 23 O ILE D 85 SHEET 7 E 8 LEU D 10 ILE D 15 -1 N ILE D 13 O LYS D 20 SHEET 8 E 8 PHE D 53 ILE D 66 -1 O GLU D 65 N LYS D 14 SHEET 1 F 8 LYS E 43 GLY E 49 0 SHEET 2 F 8 GLY E 52 ILE E 66 -1 O GLY E 52 N GLY E 49 SHEET 3 F 8 HIS E 69 VAL E 77 -1 O SER E 73 N ILE E 62 SHEET 4 F 8 VAL E 32 ILE E 33 1 N ILE E 33 O LEU E 76 SHEET 5 F 8 ILE E 84 ILE E 85 -1 O ILE E 84 N VAL E 32 SHEET 6 F 8 GLN E 18 LEU E 24 1 N LEU E 23 O ILE E 85 SHEET 7 F 8 LEU E 10 ILE E 15 -1 N ILE E 13 O LYS E 20 SHEET 8 F 8 GLY E 52 ILE E 66 -1 O GLU E 65 N LYS E 14 SITE 1 AC1 2 GLU D 21 HOH D1234 SITE 1 AC2 1 SER B 37 SITE 1 AC3 34 ARG A 8 LEU A 23 ASP A 25 GLY A 27 SITE 2 AC3 34 ALA A 28 ASP A 29 ASP A 30 GLY A 48 SITE 3 AC3 34 GLY A 49 ILE A 50 VAL A 82 ILE A 84 SITE 4 AC3 34 HOH A1008 HOH A1142 HOH A1203 HOH A1280 SITE 5 AC3 34 HOH A1318 HOH A1319 HOH A1329 ARG B 8 SITE 6 AC3 34 LEU B 23 ASP B 25 GLY B 27 ALA B 28 SITE 7 AC3 34 ASP B 29 ASP B 30 VAL B 32 GLY B 48 SITE 8 AC3 34 GLY B 49 ILE B 50 PRO B 81 VAL B 82 SITE 9 AC3 34 ILE B 84 HOH B1281 SITE 1 AC4 33 ARG D 8 LEU D 23 ASP D 25 GLY D 27 SITE 2 AC4 33 ASP D 29 ASP D 30 VAL D 32 GLY D 48 SITE 3 AC4 33 GLY D 49 ILE D 50 PRO D 81 VAL D 82 SITE 4 AC4 33 ILE D 84 HOH D1258 HOH D1362 LEU E 23 SITE 5 AC4 33 ASP E 25 GLY E 27 ALA E 28 ASP E 29 SITE 6 AC4 33 ASP E 30 VAL E 32 GLY E 48 GLY E 49 SITE 7 AC4 33 ILE E 50 PRO E 81 VAL E 82 ILE E 84 SITE 8 AC4 33 HOH E1039 HOH E1128 HOH E1215 HOH E1320 SITE 9 AC4 33 HOH E1338 SITE 1 AC5 5 MET A 36 SER A 37 HOH A1174 PRO B 39 SITE 2 AC5 5 GLY B 40 SITE 1 AC6 5 THR B 12 GLU B 65 ALA B 67 GLY B 68 SITE 2 AC6 5 LYS D 55 SITE 1 AC7 7 LYS B 7 PRO D 39 GLY D 40 HOH D1135 SITE 2 AC7 7 MET E 36 SER E 37 HOH E1358 CRYST1 51.270 62.720 59.220 90.00 98.15 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019505 0.000000 0.002793 0.00000 SCALE2 0.000000 0.015944 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017058 0.00000